Raptor Pharmaceutical Corp. (NASDAQ:RPTP) saw unusually large options trading activity on Friday. Investors purchased 7,200 put options on the stock, American Banking News.com reports.Raptor Pharmaceutical Corp. (NASDAQ:RPTP) shares after opening at $11.32 moved to $11.47 on last trade day and at the end of the day closed at $11.06. Company price to sales ratio in past twelve months was calculated as 100.49 and price to cash ratio as 7.51. Raptor Pharmaceutical Corp. (NASDAQ:RPTP) showed a negative weekly performance of -29.64%.
Intercept Pharmaceuticals (NASDAQ:ICPT) had its positive rating reaffirmed by analysts at Needham & Company. Intercept Pharmaceuticals Inc (NASDAQ:ICPT) shares fell -11.92% in last trading session and ended the day on $407.16. ICPT return on equity ratio is recorded as -103.20% and its return on assets is -63.70%. Intercept Pharmaceuticals Inc (NASDAQ:ICPT) yearly performance is 984.31%.
Echo Therapeutics Inc (NASDAQ:ECTE) a medical device company developing its Symphony® CGM System as a non-invasive, wireless continuous glucose monitoring system, is pleased to announce that its clinical study of Symphony was selected for poster presentation at the 34th International Symposium on Intensive Care and Emergency Medicine (ISICEM) from March 18-21, 2014 in Brussels, Belgium. Echo Therapeutics Inc (NASDAQ:ECTE) shares moved up 4.28% in last trading session and was closed at $3.41 while trading in range of $3.30 – $3.61 – Echo Therapeutics Inc (NASDAQ:ECTE) year to date (YTD) performance is 8.60%.
Aerie Pharmaceuticals (NASDAQ:AERI) is estimated to post a Q4 loss at $0.25 per share. Aerie Pharmaceuticals Inc (NASDAQ:AERI) weekly performance is -6.86%. On last trading day company shares ended up $20.78. Aerie Pharmaceuticals Inc (NASDAQ:AERI) distance from 50-day simple moving average (SMA50) is 4.26%. Analysts mean target price for the company is $24.25.